Skip to content
10-K

Annual Report

ARCTURUS THERAPEUTICS HOLDINGS INC. ARCT

0000950170-25-034787

← back to feed
Filed
Mar 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 4, 2025 27.12M sh
Current Liabilities FY 2024 · Dec 31, 2023 $81.99M
Total Liabilities FY 2024 · Dec 31, 2023 $150.89M
Current Assets FY 2024 · Dec 31, 2023 $386.59M
Total Assets FY 2024 · Dec 31, 2023 $429.4M
Shares Diluted FY 2024 · Dec 31, 2022 27.09M sh
Capex FY 2024 · Dec 31, 2022 $7.73M
Operating Cash Flow FY 2024 · Dec 31, 2022 $31.99M
Cash And Equivalents FY 2024 · Dec 31, 2022 $391.88M
Eps Diluted FY 2024 · Dec 31, 2022 $0.35
Eps Basic FY 2024 · Dec 31, 2022 $0.35
Sga Expense FY 2024 · Dec 31, 2022 $46.07M
Rd Expense FY 2024 · Dec 31, 2022 $147.75M
Net Income FY 2024 · Dec 31, 2022 $9.35M
Operating Income FY 2024 · Dec 31, 2022 $12.18M
Revenue FY 2024 · Dec 31, 2022 $206M
Stockholders Equity FY 2024 · Dec 31, 2021 $228.21M